Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This entry reports the completion of a Phase 1/2 clinical trial evaluating S-3304 in locally advanced non-small cell lung cancer. The study …
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLC
Clinical trial update on prognostic value of tumor volume and its changes in radical radiotherapy for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer [Phase 1]
A Phase 1 study evaluating varlilumab in combination with atezolizumab in patients with advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Suction on Post-Operative Chest Tubes [NA]
The clinical trial evaluating suction on post-operative chest tubes in non-small cell lung cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study [Phase 1, Phase 2]
Open-label Phase I/II trial evaluating PT-112 in combination with docetaxel in patients with advanced solid tumors and non-small cell lung c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy [Phase 2]
A Phase II clinical trial update reports the efficacy and safety of HM61713 as first-line therapy for non-small cell lung cancer (NSCLC). Th…
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2 [Phase 2]
Phase II safety and tolerability trial evaluating nab-paclitaxel plus carboplatin followed by nab-paclitaxel as first-line treatment in non-…
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients [Phase 1, Phase 2]
Phase I/II trial assessing safety, tolerability, and pharmacokinetics of HM61713 in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating erlotinib with SBRT for locally advanced or metastatic non-small cell lung cancer has completed; results p…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects [Phase 2, Phase 3]
A pilot Phase 2/Phase 3 trial evaluated an epidermal growth factor ointment to manage EGFR-inhibitor–related skin side effects in cancer pat…
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations [NA]
Clinical trial update indicating completion and posting of results for a study on local therapies in oligometastatic non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients [NA]
This is a completed clinical trial evaluating broncho-adventitial delivery of paclitaxel to extend airway patency in patients with malignant…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial examining Oshadi D and Oshadi R in combination with docetaxel as second-line therapy for metastatic non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating neratinib (HKI-272) in subjects with advanced non-small cell lung cancer has completed, and results have been poste…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of irinotecan for previously treated, advanced non-small cell lung cancer was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR [Phase 2]
Phase 2 study of luminespib (AUY922) in non-small cell lung cancer with EGFR exon 20 insertion mutations has completed. Results were posted …
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer [Phase 2]
A Phase 2 trial evaluating matuzumab in combination with pemetrexed for advanced non-small cell lung cancer has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients [NA]
Clinical trial update on using chemotherapy in combination with local radiotherapy and rhGM-CSF for oligometastatic stage IV non-small cell …
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing erlotinib plus tivantinib (ARQ 197) versus single-agent chemotherapy in locally advanced or metastatic non-small cel…
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating a checkpoint inhibitor in combination with erlotinib or crizotinib for EGFR- or ALK-mutated stage IV non-small ce…
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor [Phase 1]
A Phase 1 trial evaluating the safety and pharmacokinetics of ABBV-221 in adults with advanced solid tumors likely to overexpress EGFR was t…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: AUY922 for Advanced ALK-positive NSCLC [Phase 2]
Phase 2 trial update reporting results for AUY922 (ganetespib) in advanced ALK-positive non-small cell lung cancer; results have been posted…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes [Phase 2]
Phase 2 trial evaluating a tumor antigen-loaded dendritic cell-derived exosome vaccine for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC) [NA]
The study comparing endobronchial ultrasound-guided staging to mediastinoscopy in patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [NA]
The trial compares integrated palliative care versus standard palliative care in patients with advanced non-small cell lung cancer. The stud…